Skip to main content
SpringerLink
Log in

Epidemiology and Changing Demographics of Chronic Kidney Disease in the United States and Abroad

  • Chapter
  • First Online:
Nutrition in Kidney Disease

Part of the book series: Nutrition and Health ((NH))

  • 913 Accesses

Abstract

Large international differences exist in the incidence of renal replacement therapy (RRT) and the prevalence of chronic kidney disease (CKD) and RRT across the world. In some countries the incidence of RRT is now stabilizing or even declining, whereas the prevalence of RRT is still increasing. Little is known about the time trends in the prevalence of CKD. The mortality risk is high in people with CKD and this risk is even higher in patients with end-stage kidney disease. The impact of reducing risk factors on the development of CKD is still unclear. Chronic kidney disease (CKD) is increasingly recognized as a global public health problem; as many as 10–15% of the population worldwide is affected by CKD due to multiple causes. Globally, the prevalence of CKD increased by 87% between 1990 and 2016 to a total number of patients exceeding 275 million.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–69.

    Article  PubMed  Google Scholar 

  2. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888–917.

    Article  PubMed  Google Scholar 

  3. Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–81.

    Article  PubMed  Google Scholar 

  4. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

    Google Scholar 

  5. Crews DC, Bello AK, Saadi G, World Kidney Day Steering Committee. Burden, access, and disparities in kidney disease. Kidney Int. 2019;95:242–8.

    Article  PubMed  Google Scholar 

  6. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. Assessment of Global Kidney Health Care Status. JAMA. 2017;317(18):1864–81.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–82.

    Article  PubMed  Google Scholar 

  8. National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850–86.

    Article  Google Scholar 

  9. KDIGO. 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidn Int Suppl. 2012;3(1):1–P150.

    Google Scholar 

  10. Brück K, Jager KJ, Dounousi E, et al. on behalf of the European CKD Burden Consortium. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant. 2015;30:iv6–iv16.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016;31(6):868–74.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Centers for Disease Control and Prevention. Chronic kidney disease surveillance system—United States. website. http://www.cdc.gov/ckd.

  14. Imai E, Horlo M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.

    Article  PubMed  Google Scholar 

  15. Zhang L, Wang F, Wang L. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.

    Article  PubMed  Google Scholar 

  16. Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al. on behalf of European CKD Burden Consortium. CKD prevalence varies across the European general population. J Am Soc Nephrol. 2016;27:2135–47.

    Article  PubMed  Google Scholar 

  17. Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG. CKD screening and surveillance in Australia: past, present, and future. Kidney Int Rep. 2018;3(1):36–46.

    Article  PubMed  Google Scholar 

  18. Stanifer JW, Jing B, Tolan S. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):E174–81.

    Article  PubMed  Google Scholar 

  19. Cusumano AM González Bedat MC. Chronic kidney disease in Latin America: time to improve screening and detection. Clin J Am Soc Nephrol. 2008;3(2):594–600.

    Article  PubMed  Google Scholar 

  20. Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151–64.

    Article  PubMed  Google Scholar 

  21. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–81.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hallan SI, Øvrehus MA, Romundstad S. Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int. 2016;90(3):665–73.

    Article  PubMed  Google Scholar 

  23. Aitken GR, Roderick PJ, Fraser S, Mindell JS, O’Donoghue D, Day J, et al. Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open. 2014;4:e005480.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Stel VS, Brück K, Fraser S, Zoccali C, Massy ZA, Jager KJ. International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue. Nephrol Dial Transplant. 2017;32(Suppl_2):ii129–35.

    Article  PubMed  Google Scholar 

  25. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Zeimbekis A, Kastorini CM, et al. Adherence to the Mediterranean diet is associated with renal function among healthy adults: the ATTICA study. J Ren Nutr. 2010;20:176–84.

    Article  CAS  PubMed  Google Scholar 

  26. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.

    PubMed  Google Scholar 

  27. Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol. 2013;8:1685–93.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Silverwood RJ, Pierce M, Hardy R, Sattar N, Whincup P, Ferro C, et al. Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney Int. 2013;84:1262–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Böger CA, Gorski M, Li M, Hoffmann MM, Huang C, Yang Q, et al. CKDGen Consortium: association of eGFR related loci identified by GWAS with incident CKD and ESRD. PLoS Genet. 2011;7:e1002292.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21:2133–43.

    Article  PubMed  Google Scholar 

  31. de Goeij MC, Liem M, de Jager DJ, Voormolen N, Sijpkens YW, Rotmans JI, et al. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment. Nephron Clin Pract. 2012;121:c73–82.

    Article  PubMed  CAS  Google Scholar 

  32. Bruck K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, et al. Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe. Kidney Int. 2018;93:1432–41.

    Article  PubMed  Google Scholar 

  33. Eriksen BO, Tomtum J, Ingebretsen OC. Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort. Nephron Clin Pract. 2010;115:c41–50.

    Article  PubMed  Google Scholar 

  34. Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52:661–71.

    Article  CAS  PubMed  Google Scholar 

  35. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–47.

    Article  PubMed  Google Scholar 

  37. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. on behalf of the Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.

    Article  PubMed  PubMed Central  Google Scholar 

  38. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. on behalf of the Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341–52.

    Article  PubMed  CAS  Google Scholar 

  39. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–63.

    Article  PubMed  Google Scholar 

  40. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–95.

    Article  PubMed  Google Scholar 

  41. Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.

    Article  PubMed  Google Scholar 

  42. United States Renal Data System. 2018 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018.

    Google Scholar 

  43. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2016. Amsterdam UMC, location AMC, Department of Medical Informatics, Amsterdam, 2018.

    Google Scholar 

  44. Seng WH, Meng OL, Chau KT, Ganeshadeva YALM. Chapter 3: Death and survival on dialysis. In: Wong HS, Goh BL, eds. 24th report of the Malaysian Dialysis and Transplant Registry 2016. Kuala Lumpur; 2018.

    Google Scholar 

  45. Korean ESRD Registry. ESRD Registry Report 2018. Availbale at http://www.ksn.or.kr/rang_board/list.html?code=sinchart_eng.

  46. ANZDATA Registry. 41st Report, Chapter 1: incidence of end stage kidney disease. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. Available at: http://www.anzdata.org.au.

    Google Scholar 

  47. ANZDATA Registry. 41st Report, Chapter 2: prevalence of end stage kidney disease. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. Available at: http://www.anzdata.org.au.

    Google Scholar 

  48. Van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant. 2016;31:120–8.

    Article  PubMed  Google Scholar 

  49. Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2016;31:831–41.

    Article  PubMed  Google Scholar 

  50. Antlanger M, Noordzij M, van de Luijtgaarden M, Carrero JJ, Palsson R, Finne P et al. Sex Differences in Kidney Replacement Therapy Initiation and Maintenance. Clin J Am Soc Nephrol. 2019;14(11):1616–25. https://doi.org/10.2215/CJN.04400419.

  51. Ploos van Amstel S, Noordzij M, Warady BA, Cano F, Craig JC, Groothoff JW, et al. Renal replacement therapy for children throughout the world: the need for a global registry. Pediatr Nephrol. 2018;33:863–71.

    Article  PubMed  Google Scholar 

  52. Van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R. An international analysis of dialysis services reimbursement. Clin J Am Soc Nephrol. 2019;14:84–93.

    Article  PubMed  Google Scholar 

  53. Liu FX, Rutherford P, Smoyer-Tomic K, Prichard S, Laplante S. A global overview of renal registries: a systematic review. BMC Nephrol. 2015;16:31.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kramer A, Stel VS, Caskey FJ, Stengel B, Elliott RF, Covic A, et al. Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol. 2012;7:1655–63.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. An overview of regular dialysis treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2015;19:540–74.

    Article  CAS  PubMed  Google Scholar 

  56. Wu M-S, Wu I-W, Hsu K-H. Survival analysis of Taiwan renal registry data system (TWRDS) 2000–2009. Acta Nephrol. 2012;26:104–8.

    Google Scholar 

  57. Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85:158–65.

    Article  PubMed  Google Scholar 

  58. Noordzij M, Jager KJ. Increased mortality early after dialysis initiation: a universal phenomenon. Kidney Int. 2013;85:12–4.

    Article  Google Scholar 

  59. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(suppl 3):S112–9.

    Article  CAS  PubMed  Google Scholar 

  60. De Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782–9.

    Article  PubMed  Google Scholar 

  61. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758–64.

    Article  CAS  PubMed  Google Scholar 

  62. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270–7.

    Article  PubMed  Google Scholar 

  63. Van Manen JG, Van Dijk PC, Stel VS, Dekker FW, Clèries M, Conte F, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant. 2007;22:187–95.

    Article  PubMed  Google Scholar 

  64. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol. 2006;17:3510–9.

    Article  PubMed  Google Scholar 

  65. Van Dijk PC, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, et al. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int. 2007;71:53–9.

    Article  PubMed  Google Scholar 

  66. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388:294–306.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Merion RM, Goodrich NP, Johnson RJ, McDonald SP, Russ GR, Gillespie BW, et al. Kidney transplant graft outcomes in 379 257 recipients on 3 continents. Am J Transplant. 2018;18:1914–23.

    Article  PubMed  Google Scholar 

  68. Kurella Tamura M. Recognition for conservative care in kidney failure. Am J Kidney Dis. 2016;68:671–3.

    Article  PubMed  Google Scholar 

  69. Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015;88:447–59.

    Article  PubMed  Google Scholar 

  70. Hemmelgarn BR, James MT, Manns BJ, O'Hare AM, Muntner P, Ravani P, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012;307:2507–15.

    Article  CAS  PubMed  Google Scholar 

  71. Australian Institute of Health and Welfare 2016. Incidence of end-stage kidney disease in Australia 1997–2013. Cat. no. PHE 211. Canberra: AIHW.

    Google Scholar 

  72. van de Luijtgaarden MW, Noordzij M, van Biesen W, Couchoud C, Cancarini G, Bos WJ, et al. Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. Nephrol Dial Transplant. 2013;28:2604–12.

    Article  PubMed  Google Scholar 

  73. Okamoto I, Tonkin-Crine S, Rayner H, Murtagh FE, Farrington K, Caskey F, et al. Conservative care for ESRD in the United Kingdom: a national survey. Clin J Am Soc Nephrol. 2015;10:120–6.

    Article  PubMed  Google Scholar 

  74. Teruel JL, Burguera Vion V, Gomis Couto A, Rivera Gorrín M, Fernández-Lucas M, Rodríguez Mendiola N, et al. Choosing conservative therapy in chronic kidney disease. Nefrologia. 2015;35:273–9.

    Article  PubMed  Google Scholar 

  75. Foote C, Kotwal S, Gallagher M, Cass A, Brown M, Jardine M. Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: a systematic review and meta-analysis. Nephrology (Carlton). 2016;21:241–53.

    Article  Google Scholar 

  76. Shum CK, Tam KF, Chak WL, Chan TC, Mak YF, Chau KF. Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management. J Gerontol A Biol Sci Med Sci. 2014;69:308–14.

    Article  PubMed  Google Scholar 

  77. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant. 2011;26:1608–14.

    Article  PubMed  Google Scholar 

  78. Brown MA, Collett GK, Josland EA, Foote C, Li Q, Brennan FP. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. Clin J Am Soc Nephrol. 2015;10:260–8.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Wongrakpanich S, Susantitaphong P, Isaranuwatchai S, Chenbhanich J, Eiam-Ong S, Jaber BL. Dialysis therapy and conservative management of advanced chronic kidney disease in the elderly: a systematic review. Nephron. 2017;137:178–89.

    Article  PubMed  Google Scholar 

  80. Morton RL, Webster AC, McGeechan K, Howard K, Murtagh FE, Gray NA, et al. Conservative management and end-of-life care in an Australian Cohort with ESRD. Clin J Am Soc Nephrol. 2016;11:2195–203.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Murtagh FEM, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22:1955–62.

    Article  PubMed  Google Scholar 

  82. Verberne WR, Geers AB, Jellema WT, Vincent HH, van Delden JJ, Bos WJ. Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis. Clin J Am Soc Nephrol. 2016;11:633–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: WHO; 2013.

    Google Scholar 

  84. Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J Am Soc Nephrol. 2006;17(Suppl 2):S90–S7.

    Article  PubMed  Google Scholar 

  85. Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med. 1999;131:660–7.

    Article  CAS  PubMed  Google Scholar 

  86. Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, Centers for Disease Control and Prevention Expert Panel. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53:522–35.

    Article  PubMed  Google Scholar 

  87. Turner G, Wiggins K, Johnson D, et al. Cari guidelines: primary prevention of chronic kidney disease: blood pressure targets. Kidney Health Australia: Westmead; 2012.

    Google Scholar 

  88. Laine J, Kuvaja-Kollner V, Pietila E, Koivuneva M, Valtonen H, Kankaanpää E. Cost-effectiveness of population-level physical activity interventions: a systematic review. Am J Health Promot. 2014;29:71–80.

    Article  PubMed  Google Scholar 

  89. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Bala MM, Strzeszynski L, Topor-Madry R, Cahill K. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev. 2013;(6):CD004704.

    Google Scholar 

  91. McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015;(2):CD010070.

    Google Scholar 

  92. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients—absence of evidence or evidence of absence? Clin J Am Soc Nephrol. 2008;3:226–36.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    Vianda S. Stel, Marlies Noordzij & Kitty J. Jager

Authors
  1. Vianda S. Stel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlies Noordzij
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kitty J. Jager
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kitty J. Jager .

Editor information

Editors and Affiliations

  1. School of Health Professions and Nursing, Long Island University, Greenvale, NY, USA

    Jerrilynn D. Burrowes

  2. Division of Nephrology, University of Tennessee Health Science, Memphis, TN, USA

    Csaba P. Kovesdy

  3. School of Health Professions, Rutgers University–Newark, Newark, NJ, USA

    Laura D. Byham-Gray

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stel, V.S., Noordzij, M., Jager, K.J. (2020). Epidemiology and Changing Demographics of Chronic Kidney Disease in the United States and Abroad. In: Burrowes, J., Kovesdy, C., Byham-Gray, L. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana, Cham. https://doi.org/10.1007/978-3-030-44858-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44858-5_1

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-44857-8

  • Online ISBN: 978-3-030-44858-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation